Over four million Australians (one in five) are affected by allergic diseases. Allergic diseases include anaphylaxis, allergic rhinitis, asthma, eczema and others (Parliament of Australia 2020).
Anaphylaxis is the most severe type of allergic reaction. It is a potentially life-threatening medical emergency that requires urgent treatment (Allergy & Anaphylaxis Australia 2021).
Anaphylaxis accounts for about 20 deaths and 2,400 hospital admissions every year in Australia (National Allergy Council 2021). Over the past 20 years, hospital admissions for anaphylaxis have increased five-fold (Better Health Channel 2023)
Despite this, anaphylaxis is preventable (Allergy & Anaphylaxis Australia 2021).
What is Anaphylaxis?
Anaphylaxis is a severe generalised allergic reaction. Symptoms generally occur within 20 minutes to 2 hours after exposure to the allergen and may quickly escalate, with the potential to become life-threatening (Allergy & Anaphylaxis Australia 2021).
Note that not every person with an allergy will experience anaphylaxis (ASCIA 2021a).
The Australian Society of Clinical Immunology and Allergy (ASCIA) defines anaphylaxis as:
‘Any acute onset illness with typical skin features (urticarial rash or erythema/flushing, and/or angioedema), plus involvement of:
Respiratory and/or
Cardiovascular and/or
Persistent severe gastrointestinal symptoms; OR
Any acute onset of hypotension or bronchospasm or upper airway obstruction where anaphylaxis is considered possible, even if typical skin features are not present.’
(ASCIA 2023)
Anaphylaxis Signs and Symptoms
The following symptoms suggest a mild to moderate allergic reaction. Note that these symptoms may precede anaphylaxis.
Swelling of the face, lips or eyes
Rash, hives or welts
Tingling mouth
Abdominal pain and vomiting (which may indicate anaphylaxis caused by an insect allergy)
Localised swelling at a sting site (in the case of an insect sting)
Changes to the skin and mucosa.
(ASCIA 2023; ACSQHC 2021)
Anaphylaxis includes one or more of the following potentially life-threatening symptoms:
Difficult or noisy breathing
Swelling of the tongue
Tightness or swelling in the throat
Difficulty speaking and/or a hoarse voice
A wheeze or persistent cough (usually with a sudden onset)
Persistent dizziness or collapse
Pallor and floppiness (in pediatrics)
Abdominal pain and vomiting (which may indicate anaphylaxis caused by an insect allergy or injected drug allergy).
(ASCIA 2023)
Note that in up to 20% of anaphylactic reactions, skin and mucosal changes are minor or completely absent (ACSQHC 2021a).
The severity of an anaphylactic reaction may be influenced by:
Exercise
Heat
Alcohol
Amount of food eaten and how it was prepared (in anaphylaxis caused by food).
(ASCIA 2021a)
Causes of Anaphylaxis
Anaphylaxis is most likely to be triggered by foods, medicines, or insect stings (ASCIA 2023).
The onset of symptoms may depend on the allergen triggering the reaction.
Reactions caused by food usually occur within one to two hours of ingestion but can occur within 30 minutes or even several hours later
Reactions caused by stings or injected medicines usually occur within 5 to 30 minutes.
(ASCIA 2023)
About 10% of infants, 4 to 8% of children, and 2% of adults experience food allergies. Although any food can cause an allergic reaction, 90% of reactions are triggered by:
Cow's milk
Eggs
Peanuts
Tree nuts
Sesame
Soy
Fish
Shellfish
Wheat.
(ASCIA 2021b)
Medicine-related anaphylaxis is most commonly caused by:
Antibiotics
Non-steroidal anti-inflammatory drugs (NSAIDs)
Contrast-induced anaphylactoid reactions
Immunotherapy.
(Nickson 2023)
Insect sting-related anaphylaxis is most commonly caused by honeybees, wasps, or ants (Nickson 2020).
In more than 50% of cases, the trigger for anaphylaxis cannot be identified (Nickson 2020).
Less common causes of anaphylaxis include:
Physical triggers such as exercise, heat, cold, or ultraviolet light
Biological fluids such as transfusions, immunoglobulin, antivenoms and semen
Latex rubber
Tick bites
Hormonal changes such as breastfeeding or menstruation
Dialysis membranes
Hydatid cyst rupture
Aeroallergens (animals and pollen)
Food additives such as preservatives and colors
Topic medications such as antiseptics
(Nickson 2023)
Those most likely to be allergic to latex are people who are frequently exposed to it, such as healthcare workers (ASCIA 2019).
Diagnosing Anaphylaxis
Immunoglobulin E (IgE) are antibodies produced by the immune system. If you have an allergy, your immune system overreacts to an allergen by producing IgE (ASCIA 2020).
Diagnosis involves testing for raised antibodies in response to a particular allergen that is given. This can be performed through tests such as:
Full blood count with differential
Eosinophil count
Total serum immunoglobulin levels
Skin tests
Challenge tests
Radio-Allergo-Sorbent Test (RAST).
(ASCIA 2020)
One of the difficulties with recognizing an anaphylactic reaction is that there are many differential diagnoses. Some of these include:
Adrenaline (epinephrine) is the first-line treatment of anaphylaxis. It is the only treatment that decreases the amplification of an allergic response. Adrenaline reduces hospitalization and death from anaphylaxis (ACSQHC 2021). It works by:
Reducing airway mucosal edema
Inducing bronchodilation
Inducing vasoconstriction
Increasing the strength of cardiac contraction.
(ASCIA 2023)
Adrenaline also has a relatively short half-life (plasma half-life of approximately two to three minutes). Some patients may experience adverse effects such as transient pallor, palpitations, or headaches after administration (EMC 2023).
Monitoring the Patient After an Anaphylactic Reaction
The patient should not be allowed to stand or walk until they are hemodynamically stable.
Patients who received one dose of adrenaline should wait for at least one hour before standing or walking
Patients who received more than one dose of adrenaline should wait for at least four hours before standing or walking.
(ASCIA 2023)
The patient should be closely monitored (increase the frequency of observations) for at least 4 hours following their last dose of adrenaline, as there is potential for relapse. Increase the frequency of overnight observations or consider critical care if the patient is hemodynamically unstable. Overnight observation is recommended if the patient:
Experienced a severe or protracted (e.g. repeated doses of adrenaline or IV fluid resuscitation) reaction
Has a history of severe or protracted anaphylaxis
Has a concomitant illness such as asthma or arrhythmia
Lives alone or remotely from medical care
Presented for care late in the evening.
(ASCIA 2023)
Any person with anaphylaxis should have an anaphylaxis management plan. Training and education, as well as an emergency kit containing medication such as adrenaline, should be provided to the patient and their family (ACSQHC 2021).
This standard aims to improve the recognition, treatment and follow-up care of anaphylaxis (ACSQHC 2021).
The standard comprises the following six Quality Statements:
Quality Statement 1: Prompt recognition of anaphylaxis
Patients displaying the symptoms of anaphylaxis should be assessed rapidly, especially if they have a history of allergy or have been exposed to an allergic trigger.
Quality Statement 2: Immediate injection of intramuscular adrenaline
Adrenaline should be administered without delay if a patient is having an anaphylactic reaction or suspected anaphylactic reaction. Adrenaline must be administered before any other treatment, including asthma medicine, corticosteroids and antihistamines.
Quality Statement 3: Correct patient positioning
Patients experiencing an anaphylactic reaction should be laid flat. They can sit with their legs extended if they are having difficulty breathing. Patients are not permitted to stand or walk until they have been assessed as safe to do so.
Quality Statement 4: Access to a personal adrenaline injector in all healthcare settings
Patients should have access to their own adrenaline injectors at all times when receiving care and can self-medicate if required.
Quality Statement 5: Observation time following anaphylaxis
Patients who have experienced an anaphylactic reaction should be monitored for at least four hours following their last dose of adrenaline. In accordance with ASCIA’s Acute Management of Anaphylaxis Guidelines, overnight observation may be required.
Quality Statement 6: Discharge management
Prior to discharge from a healthcare facility, patients should receive:
An ASCIA Action Plan
An adrenaline injector or prescription (if there is a re-exposure risk)
Education on the suspected causative allergen, allergen avoidance strategies and post-discharge care
Arrangements for a consultation with their general practitioner and a clinical immunology/allergy specialist